Part of Oracle Corp., Cerner Innovation, Inc. is a company headquartered in the United States specializing in information retrieval services.

Ischemia Technologies, Inc. develops, manufactures and markets vitro diagnostic products with a focus on cardiovascular and acute care medicine. The Company was acquired by Inverness Medical Innovations, Inc. in March 2005. The company is headquartered in Denver, CO.

EarlySense Ltd. provides patient monitoring systems. It offers continuous patient monitoring for heart rate, respiratory rate and motion, to potentially allow the clinical team to manage early detection of patient deterioration, fall prevention and pressure ulcers prevention. The firm develops system specifically for medical surgical, general care patients who are usually monitored by nurses once every four to six hours. The company was founded by Avner Halperin, Daniel H. Lange, Guy Shinar and Yossi Gross in 2004 and is headquartered in Ramat Gan, Israel.

Hill-Rom Services, Inc., a subsidiary of Baxter International, Inc., is an American company that manufactures and sells hospital beds, furniture and health care equipment.

BiancaMed's vision is to help people enjoy healthy lives. BiancaMed offers leading health technology solutions for monitoring everyday living. Increasing healthcare costs coupled with the rise in chronic conditions, increasing obesity and the rapid aging of the population, suggests that health management will need to shift from traditional institutional settings (such as hospitals) to people's everyday environments, including the home. BiancaMed's mission is to transform personal health by providing the ultimate convenience in personal health monitoring. At the core of our product platform is a very sensitive motion sensor that detects heart rate and respiration - without having to touch a person - completely wirelessly.

Schering Corp. manufactures pharmaceutical products. It offers products in the areas of allergy and respiratory, anti-infectives, foot care, hepatitis, skin disorders, and sun care. It is a subsidiary of Schering-Plough Corp. The company is headquartered in Kenilworth, NY.

Cerner Corp. designs, develops, markets, installs, hosts and supports health care information technology, health care devices, hardware and content solutions for health care organizations and consumers. The company also provides value-added services, including implementation and training, remote hosting, operational management services, revenue cycle services, support and maintenance, health care data analysis, clinical process optimization, transaction processing, employee wellness programs and third party administrator services for employer-based health plans. It operates through the following segments: Domestic and International. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States. The International segment includes revenue contributions and expenditures linked to business activity in Aruba, Australia, Austria, the Bahamas, Belgium, Bermuda, Brazil, Canada, Cayman Islands, Chile, Denmark, Egypt, England, Finland, France, Germany, Guam, India, Ireland, Kuwait, Luxembourg, Malaysia, Mexico, Netherlands, Norway, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovakia, Spain, Sweden, Switzerland and the United Arab Emirates. The company was founded by Neal L. Patterson, Clifford W. Illig and Paul N. Gorup in 1979 and is headquartered in North Kansas City, MO.

Alexion Pharmaceuticals is a biopharmaceutical company, which is engaged in the discovery, development, and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer, and autoimmune disorders. Its marketed product Soliris (eculizumab) is a therapy approved for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH). In April 2009 and August 2009, the United States food and drug administration (FDA) and the European Commission (E.C.), respectively, granted Soliris orphan drug designation for the treatment of patients with atypical Hemolytic Uremic Syndrome (aHUS). In December 2009, its Rhode Island manufacturing facility received regulatory approval from the E.C. Or the production of Soliris.

ZOLL Medical Corp. develops and markets medical devices and related software solutions for emergency care. It provides products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management. The firm provides technologies which help fire professionals, clinicians, and rescuers in providing critical care and resuscitation treatment. It also designs software that automates data documentation and management for both clinical and non-clinical information. The company was founded by William Bright, Rolf S. Stutz, Paul M. Zoll, Leigh Stein, and Thomas M. Claflin in 1980 and is headquartered in Chelmsford, MA.

XBiotech is a biopharmaceutical company developing first-in-class antibody therapies. The Company’s lead product candidate inhibits chronic (sterile) inflammation – a condition involved in the progression of many serious and common diseases. The Company has several groundbreaking clinical trial programs in different areas of medicine including dermatology, oncology, diabetes, cachexia and cardiovascular disease.

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Volcano Co., Ltd. manufactures marine and industrial boiler burners. It offers marine boiler burners and incinerators, which include main boiler burners for LNG carriers, marine pollution preventing equipment, and oil treatment systems and industrial boiler burners, such as co-generation, environmental standards compliance, general purpose, energy saving type, and industrial boiler burners. The firm also provides burner for incinerator disposing of urban wastes, sludge, and industrial wastes, organic, alkaline, and waste liquid incineration facilities and direct combustion deodorization. The company was founded by Benji Okihara on September 3, 1928 and is headquartered in Osaka, Japan.

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Aviir is a venture-funded biotechnology company developing cutting-edge, diagnostic tests enabling accurate diagnosis and prognosis of cardiovascular disease. The company’s proprietary technology is based on ten years of research at Stanford University, and combines the scientific founder’s deep understanding of biomarker assay development and advanced biostatistics. Aviir has pursued an aggressive commercialization strategy, and initial products, including the MIRISK VP™ test, are currently on the market. The Aviir leadership team includes the founding scientists and highly experienced management.

HeartFlow focuses on precision heart care, combining human ingenuity with technology. HeartFlow’s non-invasive HeartFlow FFRCT Analysis leverages artificial intelligence to create a personalized three-dimensional model of the heart. Clinicians can use this model to evaluate the impact a blockage has on blood flow and determine the best treatment for patients. HeartFlow’s technology is reflective of our Silicon Valley roots and incorporates over two decades of scientific evidence with the latest advances in artificial intelligence. The HeartFlow FFRCT Analysis is commercially available in the United States, UK, Canada, Europe, and Japan.

Beijing Jiahe Meikang Information Technology Co., Ltd., established on 2005-07-13, Business scope includes technology development,technology transfer,technical consulting,Technical Services;software development;Basic software service,Application software service;Operation and maintenance service;Sell ​​self-developed products,electronic product,computer,Software and Auxiliary Equipment,medical instrumentsIIkind,Electrical Equipment,communication device;computer system integration;Construction Project Management;Preventive Health Consulting(Except for medical treatment activities subject to approval);health management,Health Advisory(Except for medical treatment activities subject to approval);data processing(Bank Card Center in Data Processing,PUEvalue in1.4Except for the above cloud computing data centers);Commissioned processing of electronic products;business brokerage services;Import and export,Technology Import and Export,Agent import and export;Conference Services,Undertake exhibition and display activities;Internet information service;Production of Class II Medical Devices.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Production of Class II Medical Devices,Internet information services and projects subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

ResMed provides sleep medications and non-invasive ventilation based on a visionary technology shifting diagnosis, treatment, and management of breathing sleep disorder. They treat sleep apnea, chronic obstructive pulmonary disease, and other chronic diseases.